The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis. [electronic resource]
Producer: 20150909Description: 541-52 p. digitalISSN:- 1550-6606
- Animals
- Cell Differentiation
- Dendritic Cells -- drug effects
- Encephalomyelitis, Autoimmune, Experimental -- genetics
- Gene Expression Regulation
- Humans
- Immunization
- Interleukin-10 -- genetics
- Interleukin-12 -- genetics
- Interleukin-1alpha -- genetics
- Interleukin-1beta -- genetics
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Lipopolysaccharides -- administration & dosage
- Lymph Nodes -- drug effects
- Male
- Mice
- Mice, Knockout
- Mitogen-Activated Protein Kinase 1 -- genetics
- Mitogen-Activated Protein Kinase 3 -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- STAT3 Transcription Factor -- genetics
- Signal Transduction
- Th1 Cells -- drug effects
- p38 Mitogen-Activated Protein Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.